Valour Ethereum Zero [ETH0E] vs Pharming Group N.V [PHARM] Detailed Stock Comparison

Valour Ethereum Zero
Euronext
Loading...

Pharming Group N.V
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Valour Ethereum Zero wins in 5 metrics, Pharming Group N.V wins in 9 metrics, with 0 ties. Pharming Group N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Valour Ethereum Zero | Pharming Group N.V | Better |
---|---|---|---|
P/E Ratio (TTM) | -48.41 | 57.15 | Valour Ethereum Zero |
Price-to-Book Ratio | 11.67 | 3.29 | Pharming Group N.V |
Debt-to-Equity Ratio | 0.24 | 53.57 | Valour Ethereum Zero |
PEG Ratio | N/A | -115.10 | N/A |
EV/EBITDA | -69.45 | 28.49 | Valour Ethereum Zero |
Profit Margin (TTM) | 3.43% | -2.41% | Valour Ethereum Zero |
Operating Margin (TTM) | N/A | 3.27% | N/A |
EBITDA Margin (TTM) | N/A | 3.27% | N/A |
Return on Equity | -13.20% | -3.70% | Pharming Group N.V |
Return on Assets (TTM) | -12.92% | 2.85% | Pharming Group N.V |
Free Cash Flow (TTM) | N/A | $-2.22M | N/A |
1-Year Return | 31.27% | 57.53% | Pharming Group N.V |
Price-to-Sales Ratio (TTM) | 64.11 | 2.32 | Pharming Group N.V |
Enterprise Value | $285.97M | $644.82M | Pharming Group N.V |
EV/Revenue Ratio | 55.52 | 2.21 | Pharming Group N.V |
Gross Profit Margin (TTM) | 1.63% | 90.38% | Pharming Group N.V |
Revenue per Share (TTM) | $1 | $1 | Valour Ethereum Zero |
Earnings per Share (Diluted) | $-0.79 | $-0.01 | Pharming Group N.V |
Beta (Stock Volatility) | N/A | 0.54 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Valour Ethereum Zero vs Pharming Group N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Valour Ethereum Zero | 0.00% | 0.00% | 24.89% | 60.40% | 45.34% | 11.78% |
Pharming Group N.V | 5.31% | 15.00% | 36.90% | 22.34% | 29.21% | 19.79% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Valour Ethereum Zero | 31.27% | 1,102.52% | 565.04% | 565.04% | 565.04% | 565.04% |
Pharming Group N.V | 57.53% | 1.77% | 8.49% | 283.33% | -27.22% | -96.70% |
Performance & Financial Health Analysis: Valour Ethereum Zero vs Pharming Group N.V
Metric | ETH0E | PHARM |
---|---|---|
Market Information | ||
Market Cap | €330.22M | €788.61M |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 299 | 14,295,946 |
90 Day Avg. Volume | 279 | 12,484,792 |
Last Close | €38.24 | €1.15 |
52 Week Range | €13.50 - €40.89 | €0.65 - €1.16 |
% from 52W High | -6.48% | -1.03% |
All-Time High | €40.89 (Aug 14, 2025) | €459.55 (Jul 10, 2000) |
% from All-Time High | -6.48% | -99.75% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.42% | 0.26% |
Quarterly Earnings Growth | N/A | 0.08% |
Financial Health | ||
Profit Margin (TTM) | 0.03% | -0.02% |
Operating Margin (TTM) | N/A | 0.03% |
Return on Equity (TTM) | -0.13% | -0.04% |
Debt to Equity (MRQ) | 0.24 | 53.57 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | €2.94 | €0.35 |
Cash per Share (MRQ) | €3.17 | €0.18 |
Operating Cash Flow (TTM) | €-2,327,570 | €26.65M |
Levered Free Cash Flow (TTM) | €46.07M | €19.90M |
Dividends | ||
Last 12-Month Dividend Yield | N/A | N/A |
Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Valour Ethereum Zero vs Pharming Group N.V
Metric | ETH0E | PHARM |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | -48.41 | 57.15 |
Forward P/E | N/A | -115.10 |
PEG Ratio | N/A | -115.10 |
Price to Sales (TTM) | 64.11 | 2.32 |
Price to Book (MRQ) | 11.67 | 3.29 |
Market Capitalization | ||
Market Capitalization | €330.22M | €788.61M |
Enterprise Value | €285.97M | €644.82M |
Enterprise Value Metrics | ||
Enterprise to Revenue | 55.52 | 2.21 |
Enterprise to EBITDA | -69.45 | 28.49 |
Risk & Other Metrics | ||
Beta | N/A | 0.54 |
Book Value per Share (MRQ) | €2.94 | €0.35 |
Financial Statements Comparison: Valour Ethereum Zero vs Pharming Group N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ETH0E | PHARM |
---|---|---|
Revenue/Sales | N/A | €79.50M |
Cost of Goods Sold | N/A | €7.65M |
Gross Profit | N/A | €71.85M |
Research & Development | N/A | €20.21M |
Operating Income (EBIT) | N/A | €7.68M |
EBITDA | N/A | €8.34M |
Pre-Tax Income | N/A | €6.04M |
Income Tax | N/A | €2.16M |
Net Income (Profit) | N/A | €3.88M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ETH0E | PHARM |
---|---|---|
Cash & Equivalents | N/A | €78.54M |
Total Current Assets | N/A | €209.60M |
Total Current Liabilities | N/A | €75.00M |
Long-Term Debt | N/A | €101.28M |
Total Shareholders Equity | N/A | €204.29M |
Retained Earnings | N/A | €-243.93M |
Property, Plant & Equipment | N/A | €20.95M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ETH0E | PHARM |
---|---|---|
Operating Cash Flow | N/A | €10.25M |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | €9.97M |
Debt Repayment | N/A | €-915,054 |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ETH0E | PHARM |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 299 | 14,295,946 |
Average Daily Volume (90 Day) | 279 | 12,484,792 |
Shares Outstanding | 8.63M | 583.98M |
Float Shares | N/A | 670.71M |
% Held by Insiders | N/A | 0.01% |
% Held by Institutions | N/A | 0.13% |
Dividend Analysis & Yield Comparison: Valour Ethereum Zero vs Pharming Group N.V
Metric | ETH0E | PHARM |
---|---|---|
Last 12-Month Dividend | N/A | N/A |
Last 12-Month Dividend Yield | N/A | N/A |
3-Year Avg Annual Dividend | N/A | N/A |
3-Year Avg Dividend Yield | N/A | N/A |
3-Year Total Dividends | N/A | N/A |
Ex-Dividend Date | N/A | N/A |